» Articles » PMID: 32546265

Comparative Therapeutic Index, Lethal Time and Safety Margin of Various Toxicants and Snake Antivenoms Using Newly Derived and Old Formulas

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2020 Jun 18
PMID 32546265
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The assessment of clinical efficacy and toxicity is very important in pharmacology and toxicology. The effects of psychostimulants (e.g. amphetamine), psychotomimetics (e.g. Cannabis sativus) and snake antivenoms are sometimes unpredictable even at lower doses, leading to serious intoxication and fatal consequences. Hence, there is need to re-assess some formulas for calculation of therapeutic index, lethal time and safety margin with a view to identifying therapeutic agents with remarkable toxicity potentials.

Results: The therapeutic index formula [Formula: see text] was derived from T = LD/ED and ED = [Formula: see text]. Findings have shown that, therapeutic index is a function of death reversal (s), safety factor (10) and weight of animal (Wa). However, the new safety margin formula [Formula: see text] derived from LT = [Formula: see text] and MS = [Formula: see text] shows that safety margin is a function of cube root of ratio between LT and LD and ED. Concentration (k) of toxicant at the receptor [Formula: see text] derived from D × T = K and LD = [Formula: see text] shows that therapeutic index, lethal time and safety margin is a function of drug or toxicant concentration at the receptor, the drug-receptor interaction and dose of toxicant or drug administered at a particular time.

Citing Articles

Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy.

Saganuwan S Daru. 2024; 32(2):781-800.

PMID: 38935265 PMC: 11555194. DOI: 10.1007/s40199-024-00525-y.


Determination of the median lethal dose of zinc gluconate in mice and safety evaluation.

Wang Y, Yang X, Xiao J, Wei S, Su Y, Chen X BMC Pharmacol Toxicol. 2024; 25(1):15.

PMID: 38317260 PMC: 10840281. DOI: 10.1186/s40360-024-00736-8.


Molecular docking analysis of estrogen receptor binding phytocomponents identified from the ethyl acetate extract of .

Rama V, Muruganantham B, Devaki K, Muthusami S Bioinformation. 2022; 18(3):273-283.

PMID: 36518129 PMC: 9722414. DOI: 10.6026/97320630018273.


In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.

Dutta S, Sengupta S, Tripathi A In Vitro Cell Dev Biol Anim. 2022; 58(3):255-267.

PMID: 35381943 DOI: 10.1007/s11626-022-00666-x.

References
1.
Saganuwan S . Chemistry and Effects of Brainstem Acting Drugs. Cent Nerv Syst Agents Med Chem. 2019; 19(3):180-186. DOI: 10.2174/1871524919666190620164355. View

2.
Kang S, Moon J, Chun B . Does the traditional snakebite severity score correctly classify envenomated patients?. Clin Exp Emerg Med. 2016; 3(1):34-40. PMC: 5051618. DOI: 10.15441/ceem.16.123. View

3.
Cameron C, Gregory G, Rudolph A, Heymann M . Cardiovascular effects of d-tubocurarine and pancuronium in newborn lambs during normoxia and hypoxia. Pediatr Res. 1986; 20(3):246-52. DOI: 10.1203/00006450-198603000-00010. View

4.
Ramos-Cerrillo B, de Roodt A, Chippaux J, Olguin L, Casasola A, Guzman G . Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Toxicon. 2008; 52(8):881-8. DOI: 10.1016/j.toxicon.2008.09.002. View

5.
Pore S, Ramanand S, Patil P, Gore A, Pawar M, Gaidhankar S . A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care setting. Indian J Pharmacol. 2015; 47(3):270-4. PMC: 4450551. DOI: 10.4103/0253-7613.157117. View